Shares of Atara Biotherapeutics ATRA plunged 40.5% on Thursday after ... was achieved upon treatment of EBV+ PTLD patients with the drug. As the next steps in the regulatory process, Atara ...

However, such predicted candidate drugs would not necessarily mimic the effect of ATRA treatment and induce differentiation of APL cells. We therefore generated an expression signature for ATRA ...

In parallel, Polaryx is working on PLX-100, a drug that combines PLX-200 with another approved, repurposed molecule, all-trans retinoic acid (ATRA). The addition of ATRA to PLX-200 is intended to ...